Cardinal Health Names R. Kerry Clark President, CEO, and Director
Cardinal Health, Inc., (Dublin, OH, www.cardinalhealth.com) has appointed R. Kerry Clark as president, chief executive officer, and a member of its board of directors. Clark succeeds company founder Robert D. Walter as chief executive.
Cardinal Health, Inc., (Dublin, OH, www.cardinal.com) has appointed R. Kerry Clark as president, chief executive officer, and a member of its board of directors. Clark succeeds company founder Robert D. Walter as chief executive, who will continue as chairman of the board.
Since 2002, Clark served as vice chairman of the board of The Procter & Gamble Company, where he was responsible for its $20 billion Global Family Health business, including pharmaceuticals and over-the-counter medicines. He acquired strategic, operational, and corporate management experience in leadership positions in North America and Asia during his 32 years with Procter & Gamble.
Cardinal Health, Inc. is a $75 billion, global company serving the healthcare industry with a broad portfolio of products and services. It manufactures, packages, and distributes pharmaceuticals and medical supplies, offers a range of clinical services, and develops automation products to improve the management and delivery of supplies and medication for hospitals, physician offices, and pharmacies.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
